Navigation Links
Cephalon Reports Another Strong Quarter
Date:10/28/2008

$1.08

DILUTED ADJUSTED INCOME PER COMMON

SHARE $1.18 $0.92

WEIGHTED AVERAGE NUMBER OF COMMON

SHARES OUTSTANDING 68,118 66,931

WEIGHTED AVERAGE NUMBER OF COMMON

SHARES OUTSTANDING-ASSUMING DILUTION 78,920 79,030

Notes to Reconciliation of GAAP Net Income to Adjusted Net Income

(1) To exclude the on-going amortization of acquired intangible assets ($24.0 million in 2008; $22.3 million in 2007), accelerated depreciation related to the CIMA LABS restructuring ($1.6 million in 2008), accelerated depreciation related to the proposed divestiture at the Mitry-Mory facility ($2.9 million in 2008), and the write-off of purchase commitments in excess of estimated requirements ($26.0 million in 2008).

(2) In 2008, to exclude accelerated depreciation related to the proposed divestiture at the Mitry-Mory facility. In 2007, to exclude the recognition of a milestone related to the FDA's acceptance of our NDA filing for TREANDA (bendamustine HCl).

(3) To exclude charges related to the estimated termination payments due to Takeda Pharmaceuticals North America, Inc.

(4) In 2008, to exclude charges related to the settlement of investigations by the Offices of the Attorney General of Connecticut and Massachusetts and estimated relator attorney fees. In 2007, to exclude the reserve established for the minimum liability related to the potential settlement of the investigations by the U.S. Attorney's Office.

(5) To exclude the forgiveness of a mortgage loan by the Pennsylvania Industrial Development Board ("PIDA").

(6) To exclude the accrued interest related to the settlement reached with the U.S. Attorney's Office.

(7) To exclude costs related to the CIMA LABS restructuring announced in January 2008.

(8) To reflect the tax effect of pre-tax adjustments at the applicable tax rates and certain other
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... UK (PRWEB) October 30, 2014 Caustic soda ... epoxy resins and polycarbonates. At present, China takes lead in ... , Dow, which possesses a number of facilities in the ... in the world caustic soda market in terms of output ... forecast to grow on average by 3% per year in ...
(Date:10/31/2014)... 31, 2014 Jeffrey T. Manuel, assistant ... Studies within the College of Arts and Sciences, is ... the history of alcohol-based fuels in Illinois. , ... have been working to build Illinois’ biofuels industry for ... aspect of the state's agricultural and business history. ...
(Date:10/31/2014)... October 31, 2014 The report ... Rice), Formulation (Plain, Flavored, Sweetened, Unsweetened), Channel (Supermarket, ... Global Trends & Forecast to 2018," defines and ... analysis and forecast of revenue and volume for ... is projected to reach $14 Billion by 2018 ...
(Date:10/31/2014)... 31, 2014 Stronger investment from ... finance and consumer electronics will help fuel new ... research firm IBISWorld has added a report on ... industry report collection. , The Biometrics Scan Software ... technologies such as fingerprint, iris, retina and face ...
Breaking Biology Technology:China to Dominate Caustic Soda Market Through 2018, Says Merchant Research & Consulting in Its New Study 2SIUE History Prof Manuel Working on Biofuels Book with NCERC 2SIUE History Prof Manuel Working on Biofuels Book with NCERC 3Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 2Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 3Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 4Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 2Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 3
... , , , , , , ... for nucleic acid amplification. For detailed information about a product , please ... Protector , RNase Inhibitor , , ... , is a new type of RNase ...
... , , , , , , ... size of template , Temperature optimum , Units needed for ... Rnase H activity , Combined RT and DNA Pol. , ... Expand Re- , verse Trans- , ...
... PCR that is as Flexible , as , ... , , , Choose the ... to meet your changing research needs. Central to the LightCycler , ... more than "Just another thermal cycler". It is a completely new integrated , ...
Cached Biology Technology:Product overview 2Product overview 3Product overview 4Product overview 5Product overview 6Product overview 7Properties of Reverse Transcriptases 2The LightCycler is the only System for Quantitative PCR that is as Flexible , as, You are! 2The LightCycler is the only System for Quantitative PCR that is as Flexible , as, You are! 3The LightCycler is the only System for Quantitative PCR that is as Flexible , as, You are! 4
(Date:10/31/2014)... emits over a wide part of the electromagnetic spectrum ... built in Lund, Sweden. The MAX IV facility presents ... together its component parts in a storage - ring ... a few hundred metres. Nevertheless, if these various challenges ... experiments that require source brightness and transverse coherence will ...
(Date:10/31/2014)... Ebola one important hurdle has just been cleared – ... of North Carolina at Chapel Hill and colleagues have ... be infected with Ebola and display symptoms similar to ... current issue of Science , will significantly improve ... desperately needed to curb the worldwide public health and ...
(Date:10/31/2014)...  HITLAB SM , a healthcare innovation and ... HITLAB Innovators Summit SM on December 1, ... partner with the Clinton Foundation,s Health Matters Initiative, ... Business School Alumni Club of New ... Operations Research, bringing together leaders in healthcare and ...
Breaking Biology News(10 mins):A new generation of storage -- ring 2Improved mouse model will accelerate research on potential Ebola vaccines, treatments 2HITLAB Announces Inaugural HITLAB Innovators Summit 2HITLAB Announces Inaugural HITLAB Innovators Summit 3
... PHILADELPHIA (December 8, 2013) According to Gertrude Stein, "A ... indicates that might not be the case when it comes ... collaborating institutions have found that as much as 30 percent ... any two individuals. This substantial variation is in turn reflected ...
... items to freezing temperatures may be a viable control option ... new study has found that bed bugs may be less ... article in the Journal of Economic Entomology called ... the authors describe how exposing bed bugs to freezing temperatures ...
... ORLEANS, December 7, 2013) Hematopoietic stem cell transplantation ... drug therapy for blood cancer, has become more accessible ... a result of major advances in transplant strategies and ... during the 55th American Society of Hematology Annual Meeting ...
Cached Biology News:Extensive variability in olfactory receptors influences human odor perception 2International gene therapy trial for 'bubble boy' disease shows promising early results 2International gene therapy trial for 'bubble boy' disease shows promising early results 3International gene therapy trial for 'bubble boy' disease shows promising early results 4International gene therapy trial for 'bubble boy' disease shows promising early results 5International gene therapy trial for 'bubble boy' disease shows promising early results 6International gene therapy trial for 'bubble boy' disease shows promising early results 7
Rat Cardiac Fibroblasts (RCF) (>500,000 cells)...
... Automation Buffer is a concentrated formulation of ... employing capillary action technology, as well as ... collaboration with David Brigati M.D., Department of ... This buffer is recommended for all the ...
...
... users requiring mass detection but not ... TOF Mass spectrometer is ideally suited ... for high performance mass analysis. ... analysis, protein detection, micro-satellite DNA characterization ...
Biology Products: